Techcyte, a leader in AI-powered digital pathology, announced the launch of Fusion, the first open, standards-based, SaaS platform designed to unify anatomic and clinical pathology workflows. By ...
Motive, the AI Platform for Physical Operations, today announced it has been named to G2's 2025 Best Software Awards, placing #1 on the Best Supply Chain and Logistics Products list, and landing at #4 ...
The practice of drawing blood has changed very little over the decades. It looks about the same now as it did 50 years ago.
The firm is preparing for a trial to show the efficacy of its CyPath Lung test and support a submission to the US Food and Drug Administration for marketing clearance.
In response to MAX's expansion across the Northeast, it has enhanced its Clinical Advisory Board to ... in managing oral cavity cancers and other pathology, including performing microvascular ...
Dr. Matthew Anderson was appointed co-director of the Oxford-Harrington Rare Disease Centre, a partnership between the ...
Doctors say they don't know who will run clinical departments and who will be axed, and many feel that the parent company is making decisions without consulting them or considering patients’ best ...
Unlike with a traditional blood draw, the patient does not see the needle go into the arm nor the tubes of blood. The process takes about two minutes and has a 95% success rate on the first attempt.
Several health systems across the U.S. — including Northwestern Medicine — are gearing up to try a new way of drawing blood: using a robot.
Mattiedna Johnson was a nurse, laboratory technician, and medical researcher who revolutionize modern antibiotic treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results